Pure Global
NCT06420882

Comparison of Different Treatment Methods in Patella Chondromalacia

Istanbul Medipol University Hospital·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Knee Injuries
Drug/Device/Intervention
The rehabilitation group.
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Istanbul Medipol University Hospital
Location
Istanbul, Turkey
Timeline & enrollment
Phase
N/A
Start date
May 15, 2024
End date
Nov 21, 2024
Enrollment
50 participants
Primary outcome

WOMAC,Stair climbing test,Range of motion of the joint,Star balance test,Horizontal jump test

Summary

Chondromalacia patella (CMP) is a common condition in patients presenting to healthcare units
 with anterior knee pain (1).

ICD-10 classifications
Injuries to the knee and lower legSprain and strain of other and unspecified parts of kneeOther spontaneous disruption of ligament(s) of kneeCrushing injury of kneeInjury to multiple structures of knee
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06420882
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06420882 through Pure Global AI's free database. This phase not specified trial is sponsored by Istanbul Medipol University Hospital and is currently Recruiting. The study focuses on Knee Injuries. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.